[Action of L-DOPA on the extrapyramidal symptomatology of haloperidol].
D000293:Adolescent; D000328:Adult; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D009461:Neurologic Manifestations / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D006220:Haloperidol
Azione della L-DOPA sulla sintomatologia extrapiramidale da haloperidol.